These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30818311)

  • 1. Effectiveness of a spray containing 1% malic acid in patients with xerostomia induced by graft-versus-host disease.
    Bardellini E; Amadori F; Conti G; Veneri F; Majorana A
    Med Oral Patol Oral Cir Bucal; 2019 Mar; 24(2):e190-e194. PubMed ID: 30818311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of a topical sialogogue spray containing 1% malic acid in patients with antidepressant-induced dry mouth: a double-blind, randomized clinical trial.
    Gómez-Moreno G; Aguilar-Salvatierra A; Guardia J; Uribe-Marioni A; Cabrera-Ayala M; Delgado-Ruiz RA; Calvo-Guirado JL
    Depress Anxiety; 2013 Feb; 30(2):137-42. PubMed ID: 23124914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the efficacy of a topical sialogogue spray containing malic acid 1% in elderly people with xerostomia: a double-blind, randomized clinical trial.
    Gómez-Moreno G; Cabrera-Ayala M; Aguilar-Salvatierra A; Guardia J; Ramírez-Fernández MP; González-Jaranay M; Calvo-Guirado JL
    Gerodontology; 2014 Dec; 31(4):274-80. PubMed ID: 23294350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of malic acid 1% in patients with xerostomia induced by antihypertensive drugs.
    Gómez-Moreno G; Guardia J; Aguilar-Salvatierra A; Cabrera-Ayala M; Maté-Sánchez de-Val JE; Calvo-Guirado JL
    Med Oral Patol Oral Cir Bucal; 2013 Jan; 18(1):e49-55. PubMed ID: 22926481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of 1% malic acid spray on the oral health-related quality of life of patients with xerostomia.
    Niklander S; Fuentes F; Sanchez D; Araya V; Chiappini G; Martinez R; Marshall M
    J Oral Sci; 2018; 60(2):278-284. PubMed ID: 29925712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a 1% malic acid spray for xerostomia treatment: A systematic review and meta-analysis.
    Liu G; Qiu X; Tan X; Miao R; Tian W; Jing W
    Oral Dis; 2023 Apr; 29(3):862-872. PubMed ID: 34954846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 1% malic acid spray on diabetes mellitus-induced xerostomia: A randomized clinical trial.
    Muhamed SA; Moussa EM; Aboasy NK; Gaweesh YY
    Oral Dis; 2024 Mar; 30(2):631-638. PubMed ID: 35913424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pilocarpine hydrochloride on unstimulated whole saliva flow rate and composition in patients with chronic graft-versus-host disease (cGVHD).
    Agha-Hosseini F; Mirzaii-Dizgah I; Ghavamzadeh L; Ghavamzadeh A; Tohidast-Acrad Z
    Bone Marrow Transplant; 2007 Apr; 39(7):431-4. PubMed ID: 17310130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-related outcomes in Sjögren syndrome treated with stimulants of salivary secretion: Randomized clinical trial.
    da Mata ADSP; Amaral JPAR; Thomson WM; Barcelos F; Vaz Patto J; Pereira RMN; Marques DNDS
    Oral Dis; 2020 Mar; 26(2):313-324. PubMed ID: 31814226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study.
    Nagler RM; Nagler A
    Bone Marrow Transplant; 1999 May; 23(10):1007-11. PubMed ID: 10373066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialometrical and sialochemical analysis of patients with chronic graft-versus-host disease--a prolonged study.
    Nagler RM; Nagler A
    Cancer Invest; 2003; 21(1):34-40. PubMed ID: 12643007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral disease profiles in chronic graft versus host disease.
    Bassim CW; Fassil H; Mays JW; Edwards D; Baird K; Steinberg SM; Cowen EW; Naik H; Datiles M; Stratton P; Gress RE; Pavletic SZ
    J Dent Res; 2015 Apr; 94(4):547-54. PubMed ID: 25740857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation into the use of pilocarpine as a sialagogue in patients with radiation induced xerostomia.
    Frydrych AM; Davies GR; Slack-Smith LM; Heywood J
    Aust Dent J; 2002 Sep; 47(3):249-53. PubMed ID: 12405466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of an intra-oral electrostimulator for the relief of dry mouth in patients with chronic graft versus host disease: Case series.
    Zadik Y; Zeevi I; Luboshitz-Shon N; Dakwar N; Wolff A; Shapira MY; Or R; Elad S
    Med Oral Patol Oral Cir Bucal; 2014 May; 19(3):e212-9. PubMed ID: 24121920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of toothpicks containing flavoring and flavoring plus jambu extract (spilanthol) to promote salivation in patients -diagnosed with opioid-induced dry mouth (xerostomia).
    Davis B; Davis K; Bigelow S; Healey P
    J Opioid Manag; 2017; 13(5):335-340. PubMed ID: 29199399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Prescription Sialagogues for Management of Xerostomia in Chronic Graft-versus-Host-Disease.
    Mousavian M; Sroussi H; Villa A; Cutler C; Treister N
    Transplant Cell Ther; 2021 Jun; 27(6):480.e1-480.e5. PubMed ID: 33846113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 0.1% pilocarpine mouthwash on xerostomia: double-blind, randomised controlled trial.
    Kim JH; Ahn HJ; Choi JH; Jung DW; Kwon JS
    J Oral Rehabil; 2014 Mar; 41(3):226-35. PubMed ID: 24527846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of saliva stimulants (Hybrin and malic acid) on cervical root surfaces in vitro.
    Anneroth G; Nordenram G; Bengtsson S
    Scand J Dent Res; 1980 Jun; 88(3):214-8. PubMed ID: 6932087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pilocarpine on salivary constituents in patients with chronic graft-versus-host disease.
    Nagler RM; Nagler A
    Arch Oral Biol; 2001 Aug; 46(8):689-95. PubMed ID: 11389860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural products for the management of xerostomia: a randomized, double-blinded, placebo-controlled clinical trial.
    Navarro Morante A; Wolff A; Bautista Mendoza GR; López-Jornet P
    J Oral Pathol Med; 2017 Feb; 46(2):154-160. PubMed ID: 27550537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.